DRRX - 1.68 Pre-market now at 1.70/1.77 ORADURĀ®-Methylphenidate ER Capsule Achieves Primary Endpoint in Phase 3 Study in ADHD in Taiwan http://stockcharts.com/c-sc/sc?s=DRRX&p=D&b=5&g=0&i=t28817275059&r=1502198820933 http://stockcharts.com/c-sc/sc?s=DRRX&p=W&b=5&g=0&i=t37485995606&r=1502198801751